Business Wire

SEMPERIS

12.5.2021 10:02:14 CEST | Business Wire | Press release

Share
Semperis Brings Award-Winning Hybrid Identity Protection Conference to Europe, Keynotes Announced

Semperis , the pioneer in identity-driven cyber resilience for enterprises, today announced that it will host the inaugural Hybrid Identity Protection (HIP) Europe Virtual Conference 2021 , taking place virtually on 30 June and 1 July 2021. The first European edition of the award-winning global Hybrid Identity Protection conference series, HIP Europe will bring together leading experts working at the intersection between identity and security to provide a deep dive into the latest trends and challenges in managing hybrid and multi-cloud environments.

Keynote speakers will include Microsoft MVP Tony Redmond , aka the Exchange Godfather and author of numerous books and blogs on Microsoft Exchange and Office 365, and Microsoft Directory Services MVP and identity guru John Craddock , who has played a key role architecting identity and security solutions for industry leaders including Microsoft, the UK Government and multi-national businesses.

Organisations globally are struggling to keep up with the skyrocketing proliferation of cyberattacks — including the infamous SolarWinds supply-chain attack and the Hafnium attack on Microsoft Exchange — that target identity systems, especially Active Directory. HIP Europe will connect technology gurus and practitioners in an environment where they can exchange information, share war stories, and ultimately make their networks and applications more secure.

The HIP conference has earned its place as the premier educational forum for identity-centric cybersecurity leaders tasked with defending hybrid environments. First established in the US and now coming to Europe, the conference series is designed to advance the skills of IT and cybersecurity professionals through highly technical demonstrations, expert roundtables, and networking sessions. Attendees will learn best practices from local identity and access management (IAM) experts and Microsoft Most Valuable Professionals (MVPs), and connect with peers facing similar infrastructure and security challenges.

Agenda highlights

The two-day conference programme is packed with actionable insights for practitioners, from discussing the future of cloud security to identifying and recovering from directory breaches and cyber disasters. Highlights include:

  • The Future of Microsoft Cloud Services . In this keynote session, Tony Redmond will look at the economics, software engineering, ecosystem and landscape of Microsoft 365 and discuss the reliability and security of Office 365.
  • The Future of Identity: DIDs and VCs . This keynote by John Craddock will be an introduction to the future of identity with Decentralised Identifiers (DIDs) and Verifiable Credentials (VCs). What if users owned their identity without dependence on identity providers and only needed to prove who they are once, using that proof as often as necessary?
  • Cloud Security: What’s Next? Providing a simple and unified hybrid security management engine that spans the heterogeneous space of on-premises, shared data centre and cloud is a key challenge. This session will sketch the current cloud security landscape and what challenges lie ahead for hybrid organisations.
  • Deploying a Zero Trust Infrastructure . This session will demonstrate how to implement the principles of Zero Trust within a Microsoft hybrid cloud infrastructure, building on the Microsoft security stack with Azure AD, Control and Conditional Access Management features and Microsoft 365 Defender suite.

Keynote speaker and identity guru John Craddock comments: “Almost all organisations consume services from the cloud and are possibly shifting their own services to the cloud, building valuable collaborative environments providing access for their users, partners and consumers. The security boundary stretches and morphs as we create these new hybrid systems. With these elastic boundaries, identity becomes the critical component in securing our assets and managing access control. At the Hybrid Identity Protection conference, attendees can learn from industry leaders how to identify potential vulnerabilities and protect their systems for the future. A paradigm shift is around the corner with Decentralised Identity and Verifiable Credentials. My keynote will explain the benefits of this exciting new technology.”

Guido Grillenmeier, Chief Technologist at Semperis and Microsoft MVP alumnus for Directory Services, adds: “We’re excited to bring the HIP conference to Europe for the first time. It promises an amazing line-up of the world’s foremost hybrid identity experts covering today’s hottest identity security topics: the future of cloud services, cloud security and identity itself. Zero Trust is the name of the game when it comes to preventing malicious actors from stealing the keys to your kingdom – your most privileged accounts – be it on-premises or in the cloud. HIP Europe will give solid insights into how it is done right. Due to the pandemic, this will be a fully virtual experience, and it is free to attend. Security professionals can expect to discuss learnings from recent cyber incidents, experiences in recovering from attacks and how to defend modern environments against emerging threats.”

The global HIP event was established by Semperis in 2016 and has won several awards, including the 2021 Globee Business Awards – Gold Winner, Achievement of the Year in Live Events, the 2020 Cybersecurity Excellence Awards – Best Cybersecurity Conference, the Golden Bridge Business and Innovation Awards – Gold Winner, Live Event of the Year, and the 2020 IT World Awards – Bronze Winner, Security Awareness Computer-Based Training.

HIP Europe attendees can qualify for up to 12 continuing professional education (CPE) credits.

The full conference agenda is available: https://www.accelevents.com/e/HIPEurope#agenda

Registration is free: https://www.accelevents.com/e/u/checkout/HIPEurope/tickets/order

About Hybrid Identity Protection

Mobile workforces, cloud applications and digitalisation are changing every aspect of the modern enterprise. And with radical transformation come new business risks. Hybrid Identity Protection (HIP) is the premier educational forum for identity-centric practitioners. Whatever industry sector or job function, HIP strives to provide its community the insights and relationships needed to enable and protect today’s digitally driven organisations.

Twitter https://twitter.com/HIPConf
LinkedIn https://www.linkedin.com/company/hybrid-identity-protection-conference/
Facebook https://www.facebook.com/HIPConf/

About Semperis

For security teams charged with defending hybrid and multi-cloud environments, Semperis ensures integrity and availability of critical enterprise directory services at every step in the cyber kill chain and cuts recovery time by 90%. Purpose-built for securing Active Directory, Semperis’ patented technology protects over 40 million identities from cyberattacks, data breaches, and operational errors. The world’s leading organisations trust Semperis to spot directory vulnerabilities, intercept cyberattacks in progress, and quickly recover from ransomware and other data integrity emergencies. Semperis is headquartered in New Jersey and operates internationally, with its research and development team distributed between San Francisco and Tel Aviv.

Semperis hosts the award-winning Hybrid Identity Protection conference (www.hipconf.com ). The company has received the highest level of industry accolades and was recently ranked the fourth fastest-growing company in the tri-state area and 35th overall in Deloitte’s 2020 Technology Fast 500™ . Semperis is accredited by Microsoft and recognised by Gartner.

Twitter https://twitter.com/SemperisTech
LinkedIn https://www.linkedin.com/company/semperis
Facebook https://www.facebook.com/SemperisTech
YouTube https://www.youtube.com/channel/UCycrWXhxOTaUQ0sidlyN9SA

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

SES Publishes FY2025 EU Taxonomy Restatement31.7.2026 07:30:00 CEST | Press release

SES today published a restatement of its FY2025 EU Taxonomy (Article 8) disclosure. The restatement updates the FY2025 EU Taxonomy disclosure included in the 2025 Annual Report and supersedes the previously published disclosure. The FY2025 EU Taxonomy Restatement is available on the SES website: https://www.ses.com/sites/ses_v2/files/investor-files/2026-07/EU_Taxonomy_Report_Restatement_2025.pdf Follow us on: X | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where they are. With integrated multi-orbit satellites and our global terrestrial network, we deliver resilient, seamless connectivity and the highest quality video content to those shaping what’s next. Following our Intelsat acquisition, we now offer more than 100 years of combined global industry l

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye